MFS Value Fund
MFS SERIES TRUST I · Series S000000769 · 9 share classes
data updated 2026-08-10
Fund profile
As filed in the prospectus · 2025 Q4
The funds investment objective is to seek capital appreciation.
No strategy summary for this fund. We write them from the strategy narrative a fund files, for funds holding $250m or more in net assets — a fund under that line, or one whose filing carries no narrative, has none.
| Share class | Gross | Net |
|---|---|---|
| MEIAX | 0.80% | 0.79% |
| MEIJX | 0.55% | 0.54% |
| MFEBX | 1.55% | 1.54% |
| MEICX | 1.55% | 1.54% |
| MEIIX | 0.55% | 0.54% |
| MEIGX | 1.55% | 1.54% |
| MVRRX | 1.05% | 1.04% |
| MEIHX | 0.80% | 0.79% |
| MEIKX | 0.45% | 0.44% |
Net is what a holder pays after the adviser's contractual waiver; gross is before it. A waiver can expire.
Portfolio turnover 10.00% · as of 2025 Q4
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q1
| Stocks | 99.78% |
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Feb 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| — | — | — | — | — | |
| — | — | — | — | — | |
| — | — | — | — | — | |
| — | — | — | — | — | |
| — | — | — | — | — | |
| — | — | — | — | — | |
| — | — | — | — | — | |
| — | — | — | — | — | |
| — | — | — | — | — |
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Value | Shares |
|---|---|---|---|---|
| JPM | JPMorgan Chase & CoJPM | 4.25% | $2.38B | 7.9M |
| MCK | McKesson CorpMCK | 3.43% | $1.92B | 1.9M |
| PGR | The Progressive CorpPGR | 3.01% | $1.69B | 7.9M |
| JNJ | Johnson & JohnsonJNJ | 3.00% | $1.68B | 6.8M |
| CI | The Cigna GroupCI | 2.90% | $1.62B | 5.6M |
| RTX | RTX CorpRTX | 2.79% | $1.56B | 7.7M |
| XOM | Exxon Mobil CorpXOM | 2.42% | $1.36B | 8.9M |
| BA | The Boeing CoBA | 2.36% | $1.32B | 5.8M |
| ADI | Analog Devices IncADI | 2.31% | $1.29B | 3.6M |
| MS | Morgan StanleyMS | 2.12% | $1.19B | 7.1M |
Top 10 positions are 28.58% of net assets, top 25 56.65%, across 73 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free